Selected research
Market Outlook & Growth Opportunities
Global Veterinary Infectious Disease Diagnosis Market Outlook and Growth Opportunities 2026
Market perspective
The global Veterinary Infectious Disease Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Veterinary Infectious Disease Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Veterinary Infectious Disease Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary Infectious Disease Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Veterinary Infectious Disease Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Veterinary Infectious Disease Diagnosis market include Thermo Fisher Scientific, Neogen Corporation, Virbac, IDVet, Randox Laboratories, Heska Corporation, Creative Diagnostics, Eurofins Technologies and IDEXX Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Veterinary Infectious Disease Diagnosis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Veterinary Infectious Disease Diagnosis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Veterinary Infectious Disease Diagnosis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Infectious Disease Diagnosis market.
Veterinary Infectious Disease Diagnosis Segment by Company
Thermo Fisher Scientific
Neogen Corporation
Virbac
IDVet
Randox Laboratories
Heska Corporation
Creative Diagnostics
Eurofins Technologies
IDEXX Laboratories
Zoetis
QIAGEN
Veterinary Infectious Disease Diagnosis Segment by Type
Molecular Diagnostics
Immunodiagnostics
Other Technologies
Veterinary Infectious Disease Diagnosis Segment by Application
Veterinary Laboratories
Clinics
Reference Laboratories
Research Institutes
Others
Veterinary Infectious Disease Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Veterinary Infectious Disease Diagnosis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Veterinary Infectious Disease Diagnosis key companies, revenue, market share, and recent developments.
3. To split the Veterinary Infectious Disease Diagnosis breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Veterinary Infectious Disease Diagnosis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Veterinary Infectious Disease Diagnosis significant trends, drivers, influence factors in global and regions.
6. To analyze Veterinary Infectious Disease Diagnosis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Infectious Disease Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Infectious Disease Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Infectious Disease Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Infectious Disease Diagnosis industry.
Chapter 3: Detailed analysis of Veterinary Infectious Disease Diagnosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Veterinary Infectious Disease Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Veterinary Infectious Disease Diagnosis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Molecular Diagnostics
- Immunodiagnostics
- Other Technologies
Applications
- Veterinary Laboratories
- Clinics
- Reference Laboratories
- Research Institutes
- Others
Companies covered
- Thermo Fisher Scientific
- Neogen Corporation
- Virbac
- IDVet
- Randox Laboratories
- Heska Corporation
- Creative Diagnostics
- Eurofins Technologies
- IDEXX Laboratories
- Zoetis
- QIAGEN
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Veterinary Infectious Disease Diagnosis Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Veterinary Infectious Disease Diagnosis Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary Infectious Disease Diagnosis Market Dynamics
- 2.1 Veterinary Infectious Disease Diagnosis Industry Trends
- 2.2 Veterinary Infectious Disease Diagnosis Industry Drivers
- 2.3 Veterinary Infectious Disease Diagnosis Industry Opportunities and Challenges
- 2.4 Veterinary Infectious Disease Diagnosis Industry Restraints
3 Veterinary Infectious Disease Diagnosis Market by Company
- 3.1 Global Veterinary Infectious Disease Diagnosis Company Revenue Ranking in 2025
- 3.2 Global Veterinary Infectious Disease Diagnosis Revenue by Company (2021-2026)
- 3.3 Global Veterinary Infectious Disease Diagnosis Company Ranking (2024-2026)
- 3.4 Global Veterinary Infectious Disease Diagnosis Company Manufacturing Base and Headquarters
- 3.5 Global Veterinary Infectious Disease Diagnosis Company Product Type and Application
- 3.6 Global Veterinary Infectious Disease Diagnosis Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Veterinary Infectious Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Veterinary Infectious Disease Diagnosis Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Veterinary Infectious Disease Diagnosis Market by Type
- 4.1 Veterinary Infectious Disease Diagnosis Type Introduction
- 4.1.1 Molecular Diagnostics
- 4.1.2 Immunodiagnostics
- 4.1.3 Other Technologies
- 4.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Type
- 4.2.1 Global Veterinary Infectious Disease Diagnosis Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Type (2021-2032)
- 4.2.3 Global Veterinary Infectious Disease Diagnosis Sales Value Share by Type (2021-2032)
5 Veterinary Infectious Disease Diagnosis Market by Application
- 5.1 Veterinary Infectious Disease Diagnosis Application Introduction
- 5.1.1 Veterinary Laboratories
- 5.1.2 Clinics
- 5.1.3 Reference Laboratories
- 5.1.4 Research Institutes
- 5.1.5 Others
- 5.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Application
- 5.2.1 Global Veterinary Infectious Disease Diagnosis Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Application (2021-2032)
- 5.2.3 Global Veterinary Infectious Disease Diagnosis Sales Value Share by Application (2021-2032)
6 Veterinary Infectious Disease Diagnosis Regional Value Analysis
- 6.1 Global Veterinary Infectious Disease Diagnosis Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Region (2021-2032)
- 6.2.1 Global Veterinary Infectious Disease Diagnosis Sales Value by Region: 2021-2026
- 6.2.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Veterinary Infectious Disease Diagnosis Sales Value (2021-2032)
- 6.3.2 North America Veterinary Infectious Disease Diagnosis Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Veterinary Infectious Disease Diagnosis Sales Value (2021-2032)
- 6.4.2 Europe Veterinary Infectious Disease Diagnosis Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Veterinary Infectious Disease Diagnosis Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Veterinary Infectious Disease Diagnosis Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Veterinary Infectious Disease Diagnosis Sales Value (2021-2032)
- 6.6.2 South America Veterinary Infectious Disease Diagnosis Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Veterinary Infectious Disease Diagnosis Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Veterinary Infectious Disease Diagnosis Sales Value Share by Country, 2025 VS 2032
7 Veterinary Infectious Disease Diagnosis Country-level Value Analysis
- 7.1 Global Veterinary Infectious Disease Diagnosis Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Country (2021-2032)
- 7.2.1 Global Veterinary Infectious Disease Diagnosis Sales Value by Country (2021-2026)
- 7.2.2 Global Veterinary Infectious Disease Diagnosis Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.7.2 France Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.14.2 China Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.17.2 India Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Veterinary Infectious Disease Diagnosis Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Veterinary Infectious Disease Diagnosis Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Veterinary Infectious Disease Diagnosis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific
- 8.1.1 Thermo Fisher Scientific Company Information
- 8.1.2 Thermo Fisher Scientific Business Overview
- 8.1.3 Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.1.5 Thermo Fisher Scientific Recent Developments
- 8.2 Neogen Corporation
- 8.2.1 Neogen Corporation Company Information
- 8.2.2 Neogen Corporation Business Overview
- 8.2.3 Neogen Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.2.4 Neogen Corporation Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.2.5 Neogen Corporation Recent Developments
- 8.3 Virbac
- 8.3.1 Virbac Company Information
- 8.3.2 Virbac Business Overview
- 8.3.3 Virbac Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.3.4 Virbac Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.3.5 Virbac Recent Developments
- 8.4 IDVet
- 8.4.1 IDVet Company Information
- 8.4.2 IDVet Business Overview
- 8.4.3 IDVet Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.4.4 IDVet Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.4.5 IDVet Recent Developments
- 8.5 Randox Laboratories
- 8.5.1 Randox Laboratories Company Information
- 8.5.2 Randox Laboratories Business Overview
- 8.5.3 Randox Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.5.4 Randox Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.5.5 Randox Laboratories Recent Developments
- 8.6 Heska Corporation
- 8.6.1 Heska Corporation Company Information
- 8.6.2 Heska Corporation Business Overview
- 8.6.3 Heska Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.6.4 Heska Corporation Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.6.5 Heska Corporation Recent Developments
- 8.7 Creative Diagnostics
- 8.7.1 Creative Diagnostics Company Information
- 8.7.2 Creative Diagnostics Business Overview
- 8.7.3 Creative Diagnostics Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.7.4 Creative Diagnostics Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.7.5 Creative Diagnostics Recent Developments
- 8.8 Eurofins Technologies
- 8.8.1 Eurofins Technologies Company Information
- 8.8.2 Eurofins Technologies Business Overview
- 8.8.3 Eurofins Technologies Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.8.4 Eurofins Technologies Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.8.5 Eurofins Technologies Recent Developments
- 8.9 IDEXX Laboratories
- 8.9.1 IDEXX Laboratories Company Information
- 8.9.2 IDEXX Laboratories Business Overview
- 8.9.3 IDEXX Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.9.4 IDEXX Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.9.5 IDEXX Laboratories Recent Developments
- 8.10 Zoetis
- 8.10.1 Zoetis Company Information
- 8.10.2 Zoetis Business Overview
- 8.10.3 Zoetis Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.10.4 Zoetis Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.10.5 Zoetis Recent Developments
- 8.11 QIAGEN
- 8.11.1 QIAGEN Company Information
- 8.11.2 QIAGEN Business Overview
- 8.11.3 QIAGEN Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 8.11.4 QIAGEN Veterinary Infectious Disease Diagnosis Product Portfolio
- 8.11.5 QIAGEN Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst